Description

4-(2,3-Difluorophenyl)-4,5,6,7-tetrahydro-3H-imidazo[4,5-c]pyridine is a high-purity, advanced pharmaceutical intermediate with the CAS registry number 1010904-11-6. This heterocyclic compound is a critical building block in modern medicinal chemistry, valued for its precise molecular architecture that enables targeted drug development. It is primarily sought after by research institutions and pharmaceutical manufacturers engaged in the synthesis of novel active pharmaceutical ingredients (APIs), particularly for central nervous system (CNS) and oncology applications.

Application

• Pharmaceutical Intermediate: A key synthetic precursor in the research and development of novel drug candidates.
• Medicinal Chemistry Research: Used in structure-activity relationship (SAR) studies and lead optimization for new therapeutic agents.
• Kinase Inhibitor Synthesis: Serves as a core scaffold in the production of potential kinase inhibitors for oncology treatments.
• CNS Drug Development: Employed in the synthesis of compounds targeting neurological disorders and psychiatric conditions.
• Contract Research & Manufacturing (CRO/CMO): Supplied to organizations providing custom synthesis and process development services.
• Academic Research: Utilized in university and institutional labs for exploratory chemical biology and pharmacology studies.

Basic Information

Product Name	4-(2,3-Difluorophenyl)-4,5,6,7-Tetrahydro-3H-Imidazo[4,5-C]Pyridine
CAS No.	1010904-11-6
Molecular Formula	C12H11F2N3
Molecular Weight	235.23 g/mol
Synonyms	4-(2,3-Difluorophenyl)-3,4,6,7-tetrahydro-5H-imidazo[4,5-c]pyridine; 4-(2,3-Difluorophenyl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine; 1010904-11-6; Imidazo[4,5-c]pyridine, 4-(2,3-difluorophenyl)-4,5,6,7-tetrahydro-3H-; 3H-Imidazo[4,5-c]pyridine, 4-(2,3-difluorophenyl)-4,5,6,7-tetrahydro-; AKOS025310584; CS-0446228
EINECS	Contact for details

Quality Control

Our production of 4-(2,3-Difluorophenyl)-4,5,6,7-tetrahydro-3H-imidazo[4,5-c]pyridine adheres to stringent quality management protocols to ensure batch-to-batch consistency and high purity suitable for research and development. Each lot is supported by a comprehensive Certificate of Analysis (COA) detailing identity, purity, and impurity profiles. We are committed to meeting the exacting standards required for pharmaceutical intermediates, with processes designed for traceability and reliability.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (15-25°C). This compound is hygroscopic (moisture-sensitive); therefore, the container must be kept tightly sealed to minimize exposure to atmospheric humidity. For long-term storage, consider using desiccants.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.